Artemis Medicare Services Fair Value
Artemis Medicare Services (ARTEMISMED) average fair value is ₹367.7 across 6 valuation models — P/E Based Valuation, P/B Based Valuation, Price-to-Sales Valuation, Asset-Based Valuation, Benjamin Graham Number, Discounted Cash Flow (DCF), vs a current market price of ₹279.31 (+31.65%), fair value range ₹53.84–₹829.72. See ARTEMISMED P/B ratio history to compare market price against book value per share.
Fair Value Analysis Export
ARTEMISMED Fair Value vs Current Price — Valuation Summary
ARTEMISMED average fair value, fair value range, price gap and valuation status across 6 models: P/E Based Valuation, P/B Based Valuation, Price-to-Sales Valuation, Asset-Based Valuation, Benjamin Graham Number, Discounted Cash Flow (DCF). Examine ARTEMISMED earnings for recent quarterly revenue, profit and EPS trends.
P/E Based Valuation
P/B Based Valuation
Price-to-Sales Valuation
Asset-Based Valuation
Benjamin Graham Number
Discounted Cash Flow (DCF)
ARTEMISMED Fair Value Analysis — Data Sources & Coverage
Artemis Medicare Services financial data sources, valuation methods applied and sector benchmarks used — 2026 financial year. For live price and a broader fundamental view, visit Artemis Medicare Services screener.
Available Data Sources: Financial statements, dividend history, balance sheet data , sector comparisons.
Data Currency: Financial data is from the current year (2026).
ARTEMISMED vs Healthcare Services Sector Peers — P/E, P/B & Market Cap
Artemis Medicare Services P/E ratio, P/B ratio and market capitalisation vs Healthcare Services sector peers — relative valuation comparison.
| Company | Symbol | P/E Ratio | P/B Ratio | Market Cap (₹ Cr) |
|---|---|---|---|---|
| Suraksha Diagnostic | SURAKSHA | 40.64 | 5.71 | ₹1,356 |
| One Global Service Provi… | ONEGLOBAL | 13.34 | 8.2 | ₹872 |
| Gujarat Kidney and Super… | GKSL | 81.21 | 3.81 | ₹1,080 |
| Invicta Diagnostic | INVICTA | 23.99 | 2.21 | ₹107 |
| Apollo Hospitals | APOLLOHOSP | 62.28 | 12.79 | ₹115,322 |
Important Disclaimer
This fair value analysis is for informational and educational purposes only. The calculations are based on publicly available financial data and various valuation methodologies.
This analysis does not constitute investment advice, recommendations, or suggestions to buy, sell, or hold any securities. Past performance and financial data do not guarantee future results.
Please conduct your own research and consult with qualified financial advisors before making any investment decisions. Market conditions, company fundamentals, and other factors can significantly impact actual stock performance.